PRENW — Prenetics Global Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1876431 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 35,954,000 | 23,283,000 | -9,706,000 | -23,104,000 | 175,302,000 | 56,017,000 | 54,280,000 |
| Dec 2025 | 36,558,000 | 21,588,000 | -13,136,000 | -7,501,000 | 206,073,000 | 32,131,000 | 49,707,000 |
| Sep 2025 | 23,555,000 | 14,024,000 | -6,559,000 | -7,408,000 | 196,507,000 | 13,264,000 | 35,305,000 |
| Jun 2025 | 17,680,000 | 7,289,000 | -9,869,000 | -12,410,000 | 199,106,000 | 17,249,000 | 48,214,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-21,382,000
Investing CF
$30,191,000
Financing CF
$-14,619,000
CapEx
—
Dividends Paid
$0
Buybacks
$-13,117,000
EPS Diluted TTM
—
As of
2026-06-12
Balance + Analyst (yfinance extras)
Retained Earnings
$-554,781,000
Inventory
$7,032,000
Receivables
$4,294,000
ST Investments
$31,192,000
EBIT TTM
$-38,230,000
Pretax Income TTM
$-38,464,000
Interest Exp TTM
$234,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$120,069,000
EBITDA
$-40,821,000
Free Cash Flow
$-84,654,752
Enterprise Value
—
Total Cash
$115,381,000
Total Debt
$457,000
Shares Out
—
Trailing EPS
$-11.04
Book Value
$9.76
ROE
-40.8%
ROA
-13.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 92,390,000 | -38,129,000 | -37,709,000 | 206,073,000 | 49,707,000 | — | -21,826,000 |
| Dec 2024 | 15,936,000 | -38,277,000 | -46,304,000 | 213,575,000 | 42,229,000 | — | -28,874,000 |
| Dec 2023 | 6,155,000 | -42,469,000 | -62,724,000 | 254,171,000 | 44,013,000 | — | -13,765,000 |
| Dec 2022 | 13,164,000 | -65,917,000 | -190,454,000 | 312,131,231 | 68,668,371 | — | 14,515,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.02T | $1148.84 | — |
| JNJ | JOHNSON & JOHNSON | $617.78B | $256.35 | — |
| ABBV | AbbVie Inc. | $443.36B | $250.94 | — |
| MRK | Merck & Co., Inc. | $321.57B | $130.20 | — |
| NVSEF | NOVARTIS AG | $301.30B | $158.52 | — |
News headlines (Yahoo Finance, 1h cache)
PRE Continues to Exceed Expectations and Receive Preferential Financing
2026-07-15 12:05 · Yahoo
Sector Update: Healthcare Stocks Fall Late Afternoon
2026-07-14 19:46 · Yahoo
Prenetics’ IM8 Secures $1 Billion Growth Financing from General Catalyst’s Customer Value Fund (CVF)
2026-07-14 17:35 · Yahoo
Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth
2026-06-25 12:43 · Yahoo
CEO Chat with Danny Yeung, Co-Founder and CEO of Prenetics Global
2026-06-23 16:54 · Yahoo
Sector Update: Healthcare Stocks Decline Late Afternoon
2026-06-10 19:33 · Yahoo
PRE Continues to Post Rapid Growth
2026-06-10 11:10 · Yahoo
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
2026-05-20 20:51 · Yahoo
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
2026-05-20 12:00 · Yahoo
Prenetics Global Ltd (PRE) Q1 2026 Earnings Call Highlights: Record Revenue Surge Amid ...
2026-05-14 23:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.